Coverage
-
April 29, 2015
A New Jersey federal judge on Tuesday dismissed a derivative suit brought against the leadership of American Oriental Bioengineering Inc. for allegedly lying to shareholders about the company's financial status, saying the plaintiff did not satisfy pre-suit requirements showing the board wrongfully refused to take action.
1 other articles on this case.
View all »